Literature DB >> 14981535

Hematopoietic stem cell transplantation using umbilical cord blood progenitors: review of current clinical results.

A I Benito1, M A Diaz, M González-Vicent, J Sevilla, L Madero.   

Abstract

SUMMARY: Umbilical cord blood (CB) has been rapidly established as an alternative source of stem cells to bone marrow for allogeneic-related and unrelated hematopoietic transplantation. To date, almost 70 000 CB units are available for transplantation and more than 2000 CB transplants (CBT) have been performed, mostly in children, for the treatment of a variety of malignant and nonmalignant conditions. Considerable experience has been rapidly accumulated in this field and many aspects of CBT have been elucidated, while other questions remain unresolved. A concise review of the clinical results achieved after related and unrelated CBT is presented and discussed.

Entities:  

Mesh：

Year:  2004        PMID： 14981535     DOI： 10.1038/sj.bmt.1704405

Source DB:  PubMed          Journal:  Bone Marrow Transplant        ISSN： 0268-3369            Impact factor:   5.483


  15 in total

Review 1.  Chemokine-mobilized adult stem cells; defining a better hematopoietic graft.

Authors:  L M Pelus; S Fukuda
Journal:  Leukemia       Date:  2007-11-01       Impact factor: 11.528

2.  Oct-4A isoform is expressed in human cord blood-derived CD133 stem cells and differentiated progeny.

Authors:  M Howe; J Zhao; Y Bodenburg; C P McGuckin; N Forraz; R G Tilton; R J Urban; L Denner
Journal:  Cell Prolif       Date:  2009-03-25       Impact factor: 6.831

Review 3.  Peripheral blood stem cell mobilization: new regimens, new cells, where do we stand.

Authors:  Louis M Pelus
Journal:  Curr Opin Hematol       Date:  2008-07       Impact factor: 3.284

Review 4.  G-CSF-primed BM for allogeneic SCT: revisited.

Authors:  I Pessach; I Resnick; A Shimoni; A Nagler
Journal:  Bone Marrow Transplant       Date:  2015-03-02       Impact factor: 5.483

5.  Pharmacological preconditioning for short-term ex vivo expansion of human umbilical cord blood hematopoietic stem cells by filgrastim.

Authors:  Nikolaos G Grigoriadis; Ioannis G Grigoriadis; Sofia Markoula; Minas Paschopoulos; Konstantinos Zikopoulos; Panagiotis Gr Apostolakopoulos; Ioannis S Vizirianakis; Ioannis Georgiou
Journal:  Am J Stem Cells       Date:  2016-05-15

6.  An Improved Patient-Derived Xenograft Humanized Mouse Model for Evaluation of Lung Cancer Immune Responses.

Authors:  Ismail M Meraz; Mourad Majidi; Feng Meng; RuPing Shao; Min Jin Ha; Shinya Neri; Bingliang Fang; Steven H Lin; Peggy T Tinkey; Elizabeth J Shpall; Jeffrey Morris; Jack A Roth
Journal:  Cancer Immunol Res       Date:  2019-06-11       Impact factor: 11.151

7.  Risk factors of CMV infection in patients after umbilical cord blood transplantation: a multicenter study in China.

Authors:  Juan Tong; Zimin Sun; Huilan Liu; Liangquan Geng; Changcheng Zheng; Baolin Tang; Kaidi Song; Wen Yao; Xin Liu
Journal:  Chin J Cancer Res       Date:  2013-12       Impact factor: 5.087

Review 8.  Preimplantation HLA typing: having children to save our loved ones.

Authors:  K Devolder
Journal:  J Med Ethics       Date:  2005-10       Impact factor: 2.903

9.  Unrelated Umbilical Cord Blood Transplant for Children with β-Thalassemia Major.

Authors:  Sandip A Shah; Kamlesh M Shah; Kinnari A Patel; Asha S Anand; Shailesh S Talati; Harsha P Panchal; Apurva A Patel; Sonia K Parikh; Bhavesh B Parekh; Shilin N Shukla; Shreeniwas S Raut
Journal:  Indian J Hematol Blood Transfus       Date:  2014-06-19       Impact factor: 0.900

10.  Expanded CD34+ human umbilical cord blood cells generate multiple lymphohematopoietic lineages in NOD-scid IL2rgamma(null) mice.

Authors:  Lisa J Giassi; Todd Pearson; Leonard D Shultz; Joseph Laning; Kristin Biber; Morey Kraus; Bruce A Woda; Madelyn R Schmidt; Robert T Woodland; Aldo A Rossini; Dale L Greiner
Journal:  Exp Biol Med (Maywood)       Date:  2008-08
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.